BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Acosta-Lopez S, Diaz-Bethencourt D, Concepción-Massip T, Martin-Fernandez de Basoa MC, Plata-Bello A, Gonzalez-Rodriguez A, Perez-Hernandez F, Plata-Bello J. The androgen receptor expression and its activity have different relationships with prognosis in hepatocellular carcinoma. Sci Rep 2020;10:22046. [PMID: 33328560 DOI: 10.1038/s41598-020-79177-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Montgomery EJ, Xing E, Campbell MJ, Li PK, Blachly JS, Tsung A, Coss CC. Constitutively Active Androgen Receptor in Hepatocellular Carcinoma. Int J Mol Sci 2022;23. [PMID: 36430245 DOI: 10.3390/ijms232213768] [Reference Citation Analysis]
2 Lee H, Lee I, Park S, Jung M, Yang SG, Kwon T, Lee D. Investigation of Anti-Liver Cancer Activity of the Herbal Drug FDY003 Using Network Pharmacology. Evidence-Based Complementary and Alternative Medicine 2022;2022:1-14. [DOI: 10.1155/2022/5765233] [Reference Citation Analysis]
3 Vallejo-ardila DL, De Bastiani MA, Salazar DA. Regulators of Genetic Risk for the Progression of Non-alcoholic Fatty Liver Disease to Hepatocellular Carcinoma: Reconstruction of Transcriptional Network and Signature-Based Metabolic Profiling. Interdisciplinary Cancer Research 2022. [DOI: 10.1007/16833_2022_40] [Reference Citation Analysis]
4 Moon Y, Korcsmáros T, Nagappan A, Ray N. MicroRNA target-based network predicts androgen receptor-linked mycotoxin stress. Ecotoxicol Environ Saf 2021;230:113130. [PMID: 34968797 DOI: 10.1016/j.ecoenv.2021.113130] [Reference Citation Analysis]
5 Di Vincenzo A, Russo L, Doroldi CG, Vettor R, Rossato M. Sex hormones abnormalities in non-alcoholic fatty liver disease: pathophysiological and clinical implications. Exploration of Medicine. [DOI: 10.37349/emed.2021.00049] [Reference Citation Analysis]